Early research (Phase 1)Study completedNCT03415126What this trial is testingASN007 in Patients With Advanced Solid TumorsWho this might be right forCancerMalignancyNeoplasia+16 more Asana BioSciences 49
Not applicableStudy completedNCT02672020What this trial is testingTowards an Easy-to-use Adrenal Cancer/Tumor Identity CardWho this might be right forAdrenal Gland Neoplasms Assistance Publique - Hôpitaux de Paris 448
Early research (Phase 1)Study completedNCT00005842What this trial is testingTrastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerWho this might be right forCancer National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Looking for participantsNCT02830724What this trial is testingAdministering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing CancersWho this might be right forPancreatic CancerRenal Cell CancerBreast Cancer+2 more National Cancer Institute (NCI) 124
Early research (Phase 1)Active Not RecruitingNCT02298959What this trial is testingTesting the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced CancerWho this might be right forClinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Colorectal CarcinomaMetastatic Malignant Solid Neoplasm+12 more National Cancer Institute (NCI) 59
Testing effectiveness (Phase 2)Study completedNCT02806648What this trial is testingA Trial to Assess the Activity and Safety of Palbociclib in Patients With Well and Moderately Differentiated Metastatic Pancreatic Neuroendocrine Tumors (pNET)Who this might be right forPancreatic Neuroendocrine Cancer Grupo Espanol de Tumores Neuroendocrinos 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT03915678What this trial is testingAtezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid TumorsWho this might be right forSolid Tumor, AdultPancreatic CancerVirus-associated Tumors+4 more Institut Bergonié 247
Not applicableStudy completedNCT01424878What this trial is testingStudy of Molecular Pathways in Medullary Thyroid Carcinoma and Correlation of Molecular Data With Clinical Behavior of the MTC in Individuals PatientsWho this might be right forMedullary Thyroid CarcinomaMultiple Endocrine Neoplasia Type 2 National Cancer Institute (NCI) 150
Early research (Phase 1)Active Not RecruitingNCT05907304What this trial is testingAssess Naporafenib (ERAS-254) Administered With Trametinib in Patients With RAS Q61X MutationsWho this might be right forAdvanced or Metastatic Solid Tumors Erasca, Inc. 86
Testing effectiveness (Phase 2)Study completedNCT02299089What this trial is testingPhase II Study of Subcutaneous Inj. Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours (NETs)Who this might be right forAcromegalyNeuroendocrine Tumors Camurus AB 12
Testing effectiveness (Phase 2)Study completedNCT01037790What this trial is testingPhase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With CancerWho this might be right forAdult Solid TumorAdenocarcinoma of the ColonAdenocarcinoma of the Rectum+36 more Abramson Cancer Center at Penn Medicine 304
Large-scale testing (Phase 3)Study completedNCT00002641What this trial is testingSurgery With or Without Chemotherapy in Treating Patients With Soft Tissue SarcomaWho this might be right forEndometrial CancerKidney CancerOvarian Cancer+2 more European Organisation for Research and Treatment of Cancer - EORTC 350
Early research (Phase 1)Study completedNCT01048892What this trial is testingSeneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine FeaturesWho this might be right forAdrenocortical CarcinomaGastrointestinal Carcinoid TumorKidney Cancer+3 more Children's Oncology Group 22
Not applicableStudy completedNCT01927887What this trial is testingPre-Operative Nodal Staging of Thyroid Cancer Using USPIO MRI: Preliminary StudyWho this might be right forPapillary Carcinoma of Thyroid GlandMetastatic Medullary Thyroid CancerFollicular Thyroid Cancer Lymph Node Metastasis Massachusetts General Hospital 12
Testing effectiveness (Phase 2)Study completedNCT00519896What this trial is testingSunitinib Malate in Treating Patients With Iodine-Refractory Recurrent or Metastatic Thyroid CancerWho this might be right forRecurrent Thyroid CancerStage IVA Follicular Thyroid CancerStage IVA Papillary Thyroid Cancer+5 more University of Washington 35
Not applicableStudy completedNCT04922801What this trial is testingOptimising Molecular Radionuclide TherapyWho this might be right forNeuroendocrine TumorsHyperthyroidismThyroid Cancer+1 more King's College London 50
Post-approval studies (Phase 4)Looking for participantsNCT04081701What this trial is testing68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.Who this might be right forCNS TumorsMeningiomaEsthesioneuroblastoma+4 more Weill Medical College of Cornell University 200
Early research (Phase 1)Looking for participantsNCT06041516What this trial is testingA First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath TumorsWho this might be right forNeuroendocrine CarcinomasNeuroendocrine TumorsCarcinoma, Neuroendocrine+2 more National Cancer Institute (NCI) 70
Not applicableUnknownNCT03053999What this trial is testingVariables That Are Correlated to Developing Multiple Endocrine Neoplasia (MEN) and Pancreatic Neuroendocrine Tumors (PNET)Who this might be right forMultiple Endocrine NeoplasiaPancreatic Neuroendocrine TumorsHyperparathyroidism M.D. Anderson Cancer Center 53
Testing effectiveness (Phase 2)Active Not RecruitingNCT02628067What this trial is testingStudy of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)Who this might be right forAdvanced CancerAnal CarcinomaAnal Cancer+22 more Merck Sharp & Dohme LLC 1,609